About
Eye on FDA, a law blog managed by the lawyers at global law firm Akin, is a series focused on important FDA and related regulatory developments critical to the life sciences industry.
Commentary spans topics from prescription drugs, medical devices, health information and privacy to AI, compliance, policy, and updates from the FDA, among others.
We hope this blog helps readers make it easier to understand and cope with the myriad of issues organizations encounter on a daily basis.
A Renowned Health Care & Life Sciences Legal Team
Akin's award-winning health care & life sciences practice has industry-leading experience representing hospitals and health care systems on a wide range of matters involving regulatory compliance, Medicare and Medicaid reimbursement, legislative and policy advocacy, HIPAA, fraud and abuse, transactions, financial restructuring, tax and antitrust. Our team has been named Practice Group of the Year by Law360.
Our health care innovations team combines legal, public policy, scientific and technical experience to develop and implement strategies that help clients bring cutting-edge solutions to market and maximize their market potential.
Have a question? Please contact one of the blog's managing editors below.
Partner, Akin
Drawing upon his diverse health care industry and governmental experience, Nathan provides his clients with strategic, practical advice on cutting-edge regulatory, compliance and policy matters. He has worked extensively in the FDA regulatory field and also on coverage and reimbursement matters.
Akin, an Elite Global Law Firm
Akin is a leading law firm with more than 900 lawyers in offices throughout the United States, Europe, Asia and the Middle East.